01830nas a2200301   4500000000100000008004100001260000900042653002600051653002400077653001600101653001100117653002100128653001200149653002500161653003200186100002000218700001600238700001600254700001100270700001600281700002200297245006100319856005700380300000900437490001500446520105300461022001401514       2008                            d  c200810aAntibodies, Bacterial10aAntigens, Bacterial10aGlycolipids10aHumans10aImmunoglobulin M10aleprosy10aMycobacterium leprae10aSensitivity and Specificity1 aFaria Grossi MA1 aLeboeuf MAA1 aAndrade ARC1 aLyon S1 aAntunes CMF1 aBührer-Sékula S00aThe influence of ML Flow test in leprosy classification.  uhttp://www.scielo.br/pdf/rsbmt/v41s2/en_v41s2a08.pdf  a34-80 v41 Suppl 23 a<p>This is a descriptive, exploratory study correlating ML Flow, bacilloscopy and classification of paucibacillary (PB) and multibacillary (MB), involving 1,041 new leprosy cases in 13 municipalities of Minas Gerais State, from October 2002 to March 2004. Agreement between ML Flow and the classification of the number of skin lesions and bacilloscopy was moderate (K:0.51 and K:0.48, respectively); and substantial for final classification (K:0.77). From January 2000 to March 2004, the proportion of new MB cases in Minas Gerais decreased from 78.1 to 65.8%. The reduction in the percentage of MB cases was higher in health centers that participated in the ML Flow study (73.1% to 53.3%). The difference between PB and MB in the participating and non-participating health centers from January to March 2004 was statistically significant. Implementation of the ML Flow test influenced the classification of patients, suggesting a direct and beneficial impact on patient treatment and the control of the leprosy endemic in Minas Gerais, Brazil.</p>  a1678-9849